Efficacy of post-operative pain control with the help of patient controlled wound soakers (continuous infiltration of local anaesthetic infusion) following breast reconstruction  by Pampiglione, Tom et al.
Abstracts / International Journal of Surgery 12 (2014) S13eS117S18postoperative complications was signiﬁcantly higher in Monklands
compared toWishaw (p<0.05). There was no signiﬁcant difference in rates
of readmissions, A&E visits or reoperation (p>0.05). In patients with
complications, there was no signiﬁcant difference in their deprivation
status.
Conclusions: The ERP is a safe and effective protocol for breast surgery
patients with low complication rates and its implementation halved the
inpatient admission time in our cohort. The savings derived from this
would outweigh the running costs of the ERP.
0876: PREDICTORS OF LYMPH NODE METASTASIS IN LOCALLY
ADVANCED BREAST CANCER: WHAT TO DO WITH MICROMETASTASES?
Hannah Vaughan-Williams*, Michael Rees, Rory Kokelaar,
Pawel Pietrzsak, Louise Da Silva, Sumit Goyal. The Breast Centre,
Llandough Hospital, Cardiff, UK.
Introduction: Management of the axilla in breast cancer patients is
becoming increasingly complex. We assessed the surgical management of
breast cancer in a single centre and identiﬁed factors predictive of lymph
node metastasis.
Methods: A prospectively maintained database (January 2009 e
December 2011) was used to assess patients undergoing breast cancer
surgery involving axillary staging with Sentinel Lymph Node Biopsy
(SLNB). Primary outcomes were factors predictive of positive sentinel
lymph node at index procedure. Secondary outcomes were factors pre-
dictive of further lymph node metastases at subsequent axillary node
clearance (ANC).
Results: 456 female patients (age 29-90) were included, of whom 70
(15.4%) had at least one positive node at SLNB. Of these, 17 (32%) had
micrometastases alone while the remainder had evidence of macrometa-
stasis. 60 patients (85.7%) received ANC, of whom 18 (30%) had evidence of
further positive nodes. No patients with micrometastases alone at SLNB
had evidence of further positive nodes at ANC. On multivariate analysis,
factors predictive of positive SLNB were tumour size (p<0.01) and vascular
invasion (p<0.001). The only factor predicting further node involvement at
ANC was presence of macrometastasis at SLNB (p¼0.036).
Conclusions: Our results suggest that ﬁnding micrometastases alone at
SLNB may not necessitate ANC.
1057: IS THERE STILL A ROLE FOR BONE SCINTIGRAPHY IN PATIENTS
WITH BREAST CANCER SELECTED FOR SYSTEMIC STAGING IN THE ERA
OF MULTI-DETECTOR CT?
S.R. Tee*, D.P. McCartan, J. Rothwell, J. Geraghty, D. Evoy, C.M. Quinn,
R.S. Prichard, S. Skehan, A. O'Doherty, E.W. McDermott. St Vincents
University Hospital, Dublin, Ireland.
Introduction: Approximately 7% of women will have distant metastases
when presenting with breast cancer. The aim of this study was to evaluate
the additional diagnostic yield from bone scintigraphy in patients with
newly diagnosed breast cancer undergoing CT staging of the thorax,
abdomen and pelvis.
Methods: Patients with newly diagnosed breast cancer who underwent
systemic staging with CT-TAP and bone scintigraphy were included. Results
of biopsy and staging investigations were correlated. Criteria for staging
included: Locally advanced or inﬂammatory breast cancer, Neoadjuvant
therapy, Biopsy proven axillary nodal metastases on US axillary staging, Pa-
tients undergoing mastectomy, Symptoms suggestive of metastatic disease.
Results: 135 patients (median age 59) underwent systemic staging in
2012. Seventeen patients (13%) had distant metastases. Four patients (3%)
hadmetastases tomore than one organ on CT. Of the 13 (10%) patients with
one metastatic site, 2 (1%) had liver metastases and 5 (4%) had lung me-
tastases only. Six patients (4%) had bone metastases and only one of these
involved a bone (subtrochanteric femur) metastasis not seen on CT-TAP.
CT-TAP alone would have resulted in a false negative rate of 0.7%.
Conclusions: In patients with newly diagnosed breast cancer selected for
systemic staging, multi-detector CT is a satisfactory stand-alone in-
vestigation.
1098: THE ROLE OF TSG101 IN EXOSOMAL COMMUNICATION IN TRIPLE
NEGATIVE BREAST CANCER TUMOURS AND ITS POTENTIAL AS A
CHEMOTHERAPEUTIC TARGET
Shiva Sharma*,1, Luke Gubbins 1, Karolina Weiner-Gorzel 1,
Jeremy Simpson 3, Malcolm Kell 4, Amanda McCann 2. 1UCD, School ofMedicine and Medical Science, Dublin, Ireland; 2UCD, Conway Institute for
Biomolecular and Biomedical Research, Dublin, Ireland; 3UCD, School of Biology
and Environmental Science, Dublin, Ireland; 4Department of Surgery, Mater
Misericordiae University Hospital, Dublin, Ireland.
Introduction: TSG101 is an essential protein involved in the sorting and
trafﬁcking of cell components destined for cellular processing, degradation
or cellular release, and is integral to exosome production and release.
Exosomes have the ability to carry transcriptional information and transfer
information.
Results: BT-549 TNBC cells were more sensitive to the chemotherapeutic
drug Paclitaxel compared to MDA-MB-231 TNBC cells which were more
chemoresistant. Western Blot analysis demonstrated TSG101 levels were
higher in MDA-MB-231 and remained constant after 24 and 48 hours
treatment, while the more Paclitaxel sensitive BT-549 showed decreased
TSG101 levels, which decreased after 24 and 48 hours of Paclitaxel
treatment. Using a siRNA-knockdown of TSG101, NanoSight particle
analysis revealed the size and numbers of exosomes released by these
cell lines differed. Immunohistochemical analysis of 85 breast cancer
cases on TissueMicroArray established strong cytoplasmic staining of
TSG101 in 20% of cases, while 53% of tumours demonstrated none/weak
staining of TSG101.
Conclusions: We conclude that TSG101 is differentially expressed in the
TNBC in vitro and that expression levels are inﬂuenced by Paclitaxel
treatment, and siRNA-knockdown of TSG101 impedes the release of exo-
somes suggesting that high levels of TSG101 may provide a mechanism for
the dissemination of the malignant phenotype in recipient cells.
1113: WIDE LOCAL EXCISION UNDER LOCAL ANAESTHETIC FOR EARLY
BREAST CANCER: A SURGICAL OPTION FOR THE MEDICALLY UNFIT
Deepak Selvakumar*, Christopher Davies, Rahul Chotai,
Muhammad Asad Parvaiz, Brian Isgar. Department of Breast Surgery, New
Cross Hospital, The Royal Wolverhampton NHS Trust Hospitals,
Wolverhampton, UK.
Introduction: The mainstay of treatment for early breast cancer is surgery.
However for elderly and medically unﬁt patients treatment can be chal-
lenging. We look at the use of wide local excision (WLE) performed under
local anaesthetic (LA) compared to primary endocrine therapy (PET) in this
group of patients.
Methods: All breast cancer patients aged 50 and above, receiving non-
standard therapy (WLE under LA or PET), in the last 5 years were included.
We comparedmortality and follow-up times between these two treatment
groups.
Results: A total of 85 patients were seen, 26were included in theWLE under
LA group and 59 in the PET group. There was no signiﬁcant difference in
patient age (median age 85 and 83 respectively). Patients havingWLE under
LA had signiﬁcantly lower mortality (19%, p<0.05) and longer follow-up
time (35 months, p<0.05) compared to the PET group. The primary reason
for non-standard therapy in both groups was due to poor medical ﬁtness.
Conclusion: Selection to non-standard therapy should be made using a
combination of preoperative assessment and detailed discussion with
patients. Within this subset the use of WLE performed under LA can be a
successful treatment option for motivated patients with intact cognitive
function.
1125: EFFICACY OF POST-OPERATIVE PAIN CONTROL WITH THE HELP
OF PATIENT CONTROLLED WOUND SOAKERS (CONTINUOUS INFILTRA-
TION OF LOCAL ANAESTHETIC INFUSION) FOLLOWING BREAST RECON-
STRUCTION
Tom Pampiglione*, Khurram Siddique, Iman Azmy. Chesterﬁeld Hospital,
Chesterﬁeld, UK.
Introduction: Poor pain control following breast reconstruction has been
shown to increase the patient morbidity & the length of stay. Intravenous
narcotic analgesia has signiﬁcant side effects. To prospectively assess the
efﬁcacy of pain control with patient controlled wound soakers.
Methods: A prospective cross-sectional study including all breast re-
constructions with patient controlled wound soakers performed between
Apr12- Mar 13 was conducted.
Results: A total of 36 patients with the age of *49 (37-74) were included.
Procedures included expander/implant reconstructions with dermal sling
or Strattice 72%, LD ﬂaps 16% etc. Over 70% of patients experienced either
no or mild pain in recovery. Similarly the patients who experiencedmild to
moderate pain on days 1, 2 and 3 was 86%, 92% and 93 % while severe pain
was 14% , 8% and 7% respectively. A signiﬁcant number of patients did not
require any additional pain relief 73% Vs 27% while only 4/36 reported of
nausea only. The overall patient satisfaction regarding pain control was
100%, which helped achieve a discharge of over 90% of patients by day 3.
Conclusions: The use of patient controlled wound soakers is a safe,
effective and reliable method of post-op pain control following breast
reconstruction.
*Median.
1187: RETROSPECTIVE ANALYSIS OF RE-EXCISION RATES IN BREAST
CANCER SURGERY
Michael Ding*,1, Roderick Prawiradiradja 2, Mark Yun 1, Ernest Chew4,
Habib Tafazal 3. 1Heart of England NHS Trust, Birmingham, UK; 2NHS,
London, UK; 3NHS, Birmingham, UK; 4University College London, London, UK.
Introduction: It is important to obtain sufﬁcient margins when per-
forming curative breast surgery. Surgery for re-excision is associated with
increased morbidity and postoperative complications. Our aim was to
evaluate the rate of re-excisions for inadequate margins in our unit.
Methods: A retrospective study was conducted on all surgeries performed
for breast cancer between 1/8/12 and 1/3/13 at a District General Hospital.
Data was obtained from histopathology and electronic patient records.
Results: 132 patients were included in the study. 77 WLE (Wide Local
Excision) and 55 mastectomies were performed with intraoperative
radiological margins assessment. 54.5% (n¼42) WLE were wire-guided.
The overall re-excision rate was 29.9% (n¼23). 23.8 % (n¼10) wire guided
procedures resulted in reexcision and 37.1% (n¼13) nonwire-guided un-
derwent re-excision. 7 WLE resulted in mastectomy. 34 patients had
margins of <2mm and 64.7% (n¼22) underwent re-excision.
Conclusions: Re-excision rates for breast conserving surgery remains high
despite intraoperative radiological margin assessment.
1361: LYMPHOSCINTIGRAM AND SENTINEL NODE BIOPSY: DOWE NEED
A PICTURE?
Somashree Chatterji*, Grit Dabritz. North Manchester General Hospital,
Manchester, UK.
Introduction: There is decreasing evidence supporting the use of lym-
phoscintigrams for sentinel node identiﬁcation in breast cancer. We aimed
to show if there was agreement between the number of nodes identiﬁed
pre-operatively on lymphoscintigram with that identiﬁed with dye or
gamma probe intraoperatively.
Methods: All patients of the lead consultant who had undergone a lym-
phoscintigram over a two-year period were identiﬁed using PACS. Images
and notes were analysed to compare pre- and intra-operative ﬁndings.
Results: 74 patients were identiﬁed, of which 93.2% (69) had lympho-
scintigrams identifying nodes. Of these, 18.9% (14) were positive on his-
tology. 48.6% (36) of patients who had nodes identiﬁed on
lymphoscintigram were found to have an equal number on histology.
28.4% (21) had fewer nodes identiﬁed pre-operatively than on histology,
while 23% (17) had more nodes identiﬁed pre-operatively than were
positive on histology. The false negative rate was 0.07%.
Conclusions: Our ﬁndings did not support use of routine lymphoscintig-
raphy. Current recommendations supports its use in previous axillary
surgery, and our rate of accurate correlation (48%) was poor compared
with blinded studies. The next stage would be to extend the scope of the
audit across the unit. A prospective, blinded study would better determine
causality.
1387: AN EVOLUTION IN THE SURGICAL MANAGEMENT OF PATIENTS
WITH SENTINEL LYMPH NODE METASTASES
Aisling Nic An Riogh*,1,2, Maeve McAllister 1,2, Michael J. Kerin 1,2,
Edel M. Quinn 1,2, Karl J. Sweeney 1,2. 1Division of Surgery, National
University of Ireland, University College Galway, Ireland; 2Breastcheck
Western Unit, Galway, Ireland.
Introduction: Until recently, detection of sentinel lymph node (SLN)
metastases mandated axillary clearance (AC) followed by adjuvant
chemotherapy. There is increasing evidence that this is no longer the
case. We aim to assess the impact of this evidence on our institution's
practice1.
Methods: A retrospective cohort study of patients with SLN metastases
between January 2011-December 2012 was undertaken. Data was
collected from prospective databases, hospital records and pathology
reports.
During the study period, 103 patients had SLN metastases. The
decision regarding further management was made at multidisciplinary
meetings. 57 patients progressed to AC. Of these, 22 had chemotherapy
prior to completion AC. Nine of these patients had further axillary
metastases, of whom 3 showed partial/complete chemotherapy
response.
Results: There was no statistically signiﬁcant difference in treatment
duration between patients who had chemotherapy pre or post AC.
Nor was there any difference in the treatment duration of those
who required post-operative radiotherapy and those who didn't,
(p¼0.67 in the radiotherapy group, p¼0.95 in the no radiotherapy
group).
Conclusions: In conclusion, we have observed a radical change in the
management of patients with SLN metastases. There has been a move
away from immediate AC following the identiﬁcation of SLN metastases to
chemotherapy alone or combined with completion AC.
1401: SHOULDWE BE DOING OSNA INTRAOPERATIVE ASSESSMENT FOR
PATIENTS UNDERGOING MASTECTOMY FOR DCIS?
Mohammed Elniel*, Shamaela Waheed. The Royal Marsden Hospital,
London, UK.
Introduction: Invasive disease may be found at mastectomy for DCIS, a
sentinel node biopsy (SLNB) is usually performed. If the invasive focus in
the breast is small, sufﬁcient material may not be available for determi-
nation of receptor status. The sentinel node may be the only source of this
information, but this tissue is lost if the nodes are sent for intra-operative
assessment using one-step nucleic acid ampliﬁcation (OSNA). This study
examined OSNA results and treatment decisions in patients undergoing
mastectomy for DCIS.
Methods: Prospectively collected data was examined retrospectively in
patients who underwent mastectomy, SLNB and OSNA for DCIS, thought to
be without invasive disease, in a 12-month period.
Results: Of 53 patients, 38% had micro-invasive disease in the breast.
In 77% the node(s) were sent for OSNA. Micrometastasis was found
in 12% and macrometastasis in 7%, 1 patient had both. Of the OSNA
cases, frank invasive disease was found in 27% and microinvasive disease
in 7%.
Conclusions: When analysing sentinel nodes in patients undergoing
mastectomy for DCIS it may be prudent to send the node for formal his-
tology, not OSNA, so receptor status can be performed if micro-invasion is
found.
Cardiothoracic surgery
0254: CORONARY ARTERY BYPASS GRAFTING WITHOUT A LEFT ANTE-
RIOR DESCENDING ARTERY GRAFT e IS IT WORTH IT?
Andrew McGuigan*, Rory Beattie, Alastair Graham. Department of Cardiac
Surgery, Royal Victoria Hospital, Belfast, UK.
Introduction: Revascularising the left anterior descending (LAD)
artery with a left internal mammary artery (LIMA) graft is often cited
as the advantage of surgery over stenting. Little is known about
patients undergoing coronary artery bypass grafting (CABG) without LAD
graft.
Methods: Retrospectively analysis of our unit's experience of CABG
without LAD graft was undertaken. Patients having concomitant pro-
cedures aside from CABG were excluded. The National Death Registry was
accessed for survival data.
Results: Full data was available on 91 patients, representing 2% and 25% of
our total CABG and redo CABG caseloads respectively. Mean logistic
EuroSCOREwas 5.9 and in-hospital mortality 3.2%, with O/Emortality 0.54.
Reasons for lack of LAD graft and outcomes: n (%) 5 year survival LAD not
graftable 56 (61.5%) 80.7% No obstructive LAD disease 23 (25.3%) 91.1%
Patient previous LIMA to LAD graft 11 (12.1%) 90.0%.
Conclusions: Two percent of patients undergoing isolated CABG did not
receive an LAD graft. Although the peri-operative mortality is acceptable,
patients with ungraftable LAD disease had a 5-year survival almost
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